Insider · CIK 0001994301
Stuart Cobb
officer
Files at NGNE (Neurogene Inc.). First filing May 15, 2025, latest Mar 17, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $244k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NGNE: Neurogene Inc.
NGNEOct 9, 2026 · close 26.40
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 26Weak | Neurogene Inc. | $141k 6,797 shares | -18% | +193% from low-37% from high | |
| 10Weak | Neurogene Inc. | $103k 6,797 shares | -25% | +107% from low-79% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | NGNE Neurogene Inc. | SOpen-market sale Common Stock10b5-1 | -3,991 | $20.41 | $81k | 33,303 | Mar 17, 2026 |
| Mar 13, 2026 | NGNE Neurogene Inc. | SOpen-market sale Common Stock10b5-1 | -2,658 | $21.34 | $57k | 30,645 | Mar 17, 2026 |
| Mar 13, 2026 | NGNE Neurogene Inc. | SOpen-market sale Common Stock10b5-1 | -148 | $22.08 | $3,268 | 30,497 | Mar 17, 2026 |
| Feb 20, 2026 | NGNE Neurogene Inc. | AGrant or award Common Stock | +16,500 | $0.00 | $0 | 37,294 | Feb 24, 2026 |
| May 14, 2025 | NGNE Neurogene Inc. | SOpen-market sale Common Stock10b5-1 | -6,797 | $15.15 | $103k | 20,794 | May 15, 2025 |
| Mar 26, 2025 | NGNE Neurogene Inc. | AGrant or award Common Stock | +7,200 | $0.00 | $0 | 27,591 | Mar 28, 2025 |
| Mar 26, 2025 | NGNE Neurogene Inc. | AGrant or award Employee Stock Option (Right to buy)derivative | +42,900 | $0.00 | $0 | 42,900 | Mar 28, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.